Treatment Selection of JAK Inhibitors for the Management of AD

Expert dermatologists speak on shared-decision making between the patient and the provider when it comes to selecting the right therapy for AD.

Related Keywords

Christopher Bunick ,Lisa Swanson ,Alexandra Golant , ,Peter Lio ,Jak Inhibitors ,Experience ,Dosing ,Switching ,Inadequate ,Response ,Systemic ,Topical ,Suppressed Disease ,Standard Of Care ,